Andrew K Hastings Selected Research

Andrew K Hastings Research Topics

9	Infections 01/2021 - 08/2012
6	Zika Virus Infection 03/2019 - 01/2017
3	Virus Diseases (Viral Diseases) 03/2019 - 08/2012
2	Neoplasms (Cancer) 01/2016 - 05/2014
2	Lung Neoplasms (Lung Cancer) 01/2016 - 05/2014
1	West Nile Fever 01/2019
1	Bites and Stings (Sting) 01/2019
1	Malaria 11/2018
1	Fetal Death 01/2018
1	Coinfection 01/2016
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Reinfection 11/2014

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2018
4	VaccinesIBA 01/2019 - 06/2014
3	AntibodiesIBA 01/2019 - 11/2018
2	ALW-II-41-27IBA 01/2016 - 05/2014
2	Monoclonal AntibodiesIBA 01/2015 - 08/2012
2	EpitopesIBA 11/2014 - 08/2012
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 03/2019
1	Salivary Proteins and PeptidesIBA 01/2019
1	Immune Sera (Antisera)IBA 11/2018
1	Staphylococcal Protein A (Protein A)IBA 11/2018
1	Interferon Type IIBA 01/2018
1	Testosterone (Sustanon)FDA Link 02/2017
1	InterferonsIBA 01/2017
1	c-Mer Tyrosine KinaseIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	IntegrinsIBA 12/2015
1	Dynamins (Dynamin)IBA 12/2015
1	CytokinesIBA 11/2014
1	Peptides (Polypeptides)IBA 11/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014

2	Therapeutics 03/2019 - 01/2016